Comprehensive Preclinical Study for Squirrelpox Virus in Drug Development & Diagnostic Solution

Overview

The Squirrelpox Virus (SQPV) belongs to the Orthopoxvirus genus and predominantly infects squirrel populations, including the European red squirrel (Sciurus vulgaris). The Squirrelpox Virus leads to skin lesions and neurological disorders, which can result in death during severe cases. SQPV spreads through physical contact between animals and through parasitic carriers like fleas. SQPV presents a threat to wildlife conservation because of its potential to negatively impact the red squirrel population and its ability to transmit between different species. The virus presents a severe danger to wildlife diversity, even though humans have not shown widespread infection. Creative Biolabs provides extensive preclinical research services for viral research that involve virus isolation techniques, as well as viral load measurements and analysis of host-pathogen interactions. Our specialized experts develop advanced animal and laboratory models along with immune assessment protocols and therapy tests to back vaccine and treatment creation for viruses such as SQPV.

Fig.1 SQPV phylogeny and genome structure.¹

Accelerated SQPV Preclinical Research Services

• For Therapeutics Development

In Vitro Antiviral Efficacy Assays

• Cytotoxicity Assay (MTT, MTS, or Cell Viability Assays): To assess the cytotoxicity of the therapeutic candidate, ensuring it is not harmful to host cells.
• Plaque Reduction Assay: Measures the ability of the therapeutic to reduce viral plaques formed by the Squirrelpox Virus in cell cultures.
• Viral Load Quantification: Quantification of viral RNA/DNA in cell culture supernatants to assess the reduction in viral replication after treatment with the candidate.
• Time-of-Addition Assay: To evaluate the mechanism of action of the therapeutic, assessing whether it inhibits viral entry, replication, or release.
• Inhibition of Viral Entry Assays: Measures the therapeutic's ability to prevent the virus from entering host cells.

In Vivo Efficacy Studies (Animal Models)

• Squirrelpox Virus Challenge Studies in Rodent Models: Involves infecting animals (typically mice or non-human primates, if applicable) with SQPV to evaluate the therapeutic candidate's efficacy in preventing or reducing viral load and disease severity.
• Dosing and Treatment Protocols: Studies are done to evaluate the optimal dosage, frequency of administration, and timing of the therapy for maximum antiviral efficacy.
• Clinical Signs Assessment: Monitoring of animal health, including weight loss, body temperature, clinical symptoms, and overall well-being, to evaluate therapeutic efficacy and safety.
• Histopathological Studies: Post-treatment tissue analysis to assess the level of viral infection in organs (e.g., skin, lungs, liver), inflammation, and damage.
• Survival Studies: Evaluating the survival rate of treated versus untreated animals after SQPV infection.

• For Diagnostics Development

Antigen Detection Assays

• Enzyme-Linked Immunosorbent Assay (ELISA): A common assay to detect viral antigens in serum, plasma, or tissue homogenates. The assay uses antibodies specific to SQPV antigens (e.g., viral capsid proteins) for detection.
• Immunohistochemistry (IHC): Used for detecting SQPV antigens in tissue sections. This is particularly useful for assessing viral infection in tissues and determining the localization of the virus within specific organs or skin lesions.
• Lateral Flow Assay (LFA): A rapid diagnostic test that provides a quick result for antigen detection. Like a pregnancy test, this can be used in the field for preliminary diagnosis of SQPV infection.
• Flow Cytometry: Can be used for detecting SQPV antigens on infected cells in blood or tissue samples, allowing for more sensitive and quantitative detection.

Nucleic Acid Detection Assays

• Quantitative PCR (qPCR): Measures viral load and can be used to monitor the progression of infection and therapeutic responses.
• Loop-Mediated Isothermal Amplification (LAMP): A rapid, sensitive, and simple alternative to PCR, LAMP can detect SQPV nucleic acids without the need for complex laboratory equipment, making it suitable for point-of-care testing.
• Nucleic Acid Lateral Flow Assay (NALFIA): A rapid test based on nucleic acid hybridization, combining PCR sensitivity with LFA simplicity. This can be used in field settings for quick molecular diagnostics.
• Southern Blotting/Hybridization: Used for detecting larger quantities of viral DNA, particularly when validating the presence of SQPV in tissue samples.

Antibody Detection Assays (Serology)

• Enzyme-Linked Immunosorbent Assay (ELISA) for Antibodies: A commonly used technique to detect specific antibodies (IgM and IgG) against SQPV. This test is typically performed in serum or plasma samples and can indicate recent or past infection.
• Western Blotting: This is used for more detailed confirmation of the presence of specific antibodies against SQPV, often used in research or for confirmatory diagnostics after an initial positive result from ELISA.
• Immunofluorescence Assay (IFA): Can be used to detect both viral antigens and antibodies. In this test, patient serum is incubated with cells infected with SQPV, and fluorescence is used to visualize antibody binding.
• Neutralization Assay: Measures the ability of antibodies to neutralize the infectivity of SQPV. This assay is more specialized and is often used for vaccine development or evaluating immune responses after treatment.

Request a Quote

Products for SQPV Research

The market for research products related to the SQPV remains small because the virus represents a newly identified pathogen with specialized application in wildlife research. SQPV lacks specialized diagnostic tools, but scientists can utilize PCR-based assays for viral DNA detection in research settings. Development efforts are underway to create antigen detection techniques and serological tests for SQPV infection monitoring and antibody response tracking in wildlife.

Get a Quote Today

Applications

1. Wildlife Conservation: SQPV affects red squirrel populations while research provides insights into transmission methods and pathogenesis, which helps manage outbreaks within conservation programs.

2. Zoonotic Surveillance: SQPV's ability to transfer between animal species emphasizes the need to track risks of disease spread from wildlife to humans.

3. Viral Pathogenesis: Research on SQPV helps scientists study orthopoxviruses, which enhances understanding of viral replication and immune responses while supporting antiviral development.

4. Vaccine & Therapeutic Development: SQPV provides research platforms for vaccine and antiviral therapy testing, which helps understand treatment options for other poxviruses.

Advantages

1. Expertise and Experience: Our team comprises expert researchers who specialize in viral pathogenesis detection techniques and therapeutic development for SQPV.

2. Comprehensive Services: Our services include virus detection and diagnostic assay development, as well as preclinical model testing and therapeutic evaluation.

3. State-of-the-Art Technology: Our research facilities utilize the most advanced technologies for PCR and antigen detection, along with serological assays and viral load quantification to deliver dependable, high-quality results.

4. Customized Solutions: Our services are customized to support specific research requirements in conservation studies as well as vaccine development and antiviral drug screening.

FAQs